| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_238a0cbb4d846151b3a4844bad7f9879
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bceb71676971f1383ae2a7e5ccaa7da |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate |
2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53e9c3eedeb1b43cd1c408ad289f7aa3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7d852c434d9eb38b0e7f0a9ea61e7b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d8556a22a56a205cd823f6506293005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_505e0b703253fea7ee6c85584bb671de |
| publicationDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2670683-T3 |
| titleOfInvention |
Crystal forms of an androgen receptor modulator |
| abstract |
A crystalline form B of 4- [7- (6-cyano-5-trifluoromethylpyridin-3-yl) -8-oxo-6-thioxo-5,7-diazaspiro [3.4] oct-5-yl] -2- fluoro -N-methylbenzamide that is characterized by having at least one of: a) a powder X-ray diffraction pattern (XRPD) same as a. 5 shown in Figure 2; b) a powder X-ray diffraction pattern (XRPD) with characteristic peaks at 12.1 + - 0.1 ° 2-Theta, 16.0 + - 10 0.1 ° 2-Theta, 16.7 + - 0.1 ° 2-Theta, 20.1 + - 0.1 ° 2-Theta, 20.3 + - 0.1 ° 2-Theta; c) unit cell parameters equal to the following at -173 ° C: ** Formula ** d) the same powder X-ray diffraction pattern (XRPD) as (a) or (b) storage after 40 ° C and 75% RH for at least one week; or e) the same powder X-ray diffraction pattern (XRPD) as (a) or (b) after storage at 25 ° C and 92% RH for 12 days. |
| priorityDate |
2012-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |